Brazilian President Luiz Inácio Lula da Silva Friday participated in the city of Nova Lima, state of Minas Gerais, in the opening of the Biomm recombinant human insulin-producing plant.

India's Biocon has partnered with US-based Mylan to sell Indian-made biogenerics globally. Bangalore-based Biocon sees the collaboration with Mylan, the world's third-largest generics producer ...

Biocon Limited and its European partner Zentiva have received regulatory approval for their generic version of Liraglutide in the European Union through the Decentralized Procedure (DCP), the ...

Shares of Biocon soared over 4 percent on January 13 after the US Food and Drug Administration cleared arm Biocon Biologics' insulin facility in Malaysia, putting an end to a major regulatory ...

The brokerage's optimism stems from an expected operational turnaround for Biocon, driven by key biosimilar launches and a recovery in generics sales. HSBC highlighted several factors that could ...